George Ng

Insider Reports History

Entity
Individual
Location
C/O Sorrento Therapeutics, Inc., 6042 Cornerstone Court West, Suite B, San Diego, CA
Signature
/s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Ng:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Restricted Stock Units 800K $1.96M $2.45 Aug 8, 2023 Direct
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 20K $54K $2.70 Jan 30, 2024 By Family Trust
Calidi Biotherapeutics, Inc. Director Common Stock 18.5K $33.4K $1.80 Sep 12, 2023 Direct
Calidi Biotherapeutics, Inc. Director Common Stock 9.55K $17.2K $1.80 Sep 12, 2023 By Peng Ventures, LLC

Insider Reports Filed by George Ng

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Jan 30, 2024 1 $27K 4 Jan 31, 2024 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Oct 12, 2023 1 $25K 4 Oct 12, 2023 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Oct 10, 2023 1 $25K 4 Oct 10, 2023 Chief Executive Officer, Director
CLDI Calidi Biotherapeutics, Inc. Sep 12, 2023 0 $0 3 Sep 25, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Aug 8, 2023 2 $0 4 Aug 9, 2023 Chief Executive Officer
PCSA Processa Pharmaceuticals, Inc. Aug 8, 2023 0 $0 3 Aug 9, 2023 Chief Executive Officer